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Abstract 
 
Introduction 
Yaws is a neglected tropical disease and results in lesions of skin, soft tissues and bones. PCR 
plays an important part in surveillance.  
 
Methods 
Children suspected to have yaws were enrolled. From the largest lesion paired swabs were 
collected; one into transport medium and one as a dry swab. In children with multiple lesions 
we collected additional swabs from up to four subsequent lesions. Swabs in transport medium 
were maintained in a cold-chain whilst dry swabs were stored at ambient temperature. Swabs 
were tested by PCR for Treponema pallidum and Haemophilus ducreyi.   
 
Results 
Of 55 individuals, 10 (18%) had at least 1 positive PCR for T. pallidum and 12 (22%) had at least 
1 positive result for H. ducreyi. Concordance was 100% between swabs in transport medium 
and dry swabs. One patient had PCR-confirmed yaws on the swab of a third lesion when both 
the first and second lesions were PCR-negative.  
 
Discussion 
Storing swabs in transport medium and transporting in  a cold chain did not improve yield, 
however detection of T. pallidum is increased by swabbing additional lesions. As the target for 
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yaws is eradication approaches to sample collection need revisiting to ensure cases are not 
missed.  
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Introduction 
 
Yaws, caused by the Treponema pallidum subsp. pertenue, is a neglected tropical disease (NTD) 
and results in lesions of the skin, soft tissues and bones[1,2]. The disease predominantly affects 
children and is known to be endemic in 15 countries[3]. Transmission of  yaws occurs from 
person to person through direct skin contact with infectious exudates of early skin lesions of 
infected individuals[4]. Early, active yaws is characterised by papillomatous and ulcerative 
lesions which are highly infectious. Untreated lesions of early yaws may spontaneously heal but 
periods of relapse to infectious yaws may continue for a number of years. In a proportion of 
untreated individuals the disease progresses to highly destructive lesions of the skin and bones 
which result in chronic disfigurement and disability[2,5].  
 
Interest in yaws has increased in recent years, following studies showing azithromycin to be 
highly effective in the treatment of yaws and that community mass treatment by azithromycin 
reduces the prevalence of both active and latent disease[6–10], culminating in renewed efforts 
by the World Health Organization (WHO) to achieve global yaws eradication[11]. Despite global 
eradication efforts led by WHO and UNICEF between 1952 and 1965 and further national 
efforts between 1981 and 1983, Ghana remains endemic for yaws, and reports the most cases 
of any country in Africa[3,4]. Yaws remains an important public health problem in the country 
and is reported in all the 10 regions of Ghana and nearly all the districts in the country.  In 2008 
Ghana launched the National Yaws Eradication Program (NYEP). The programme has succeeded 
in increasing the number of contacts treated per yaws case from 3.5 in 2008 to 10.8 in 
2013[12]and in conducting pilot implementations of the WHO ‘Morges’ strategy for yaws 
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eradication[10,11]. Currently in Ghana, as in other endemic countries, the diagnosis of yaws is 
most often based on clinical grounds alone without the aid of serological or molecular 
investigations. Studies in many settings have indicated that clinical diagnosis alone may be 
unreliable[13–15] and WHO has strongly advocated the introduction of diagnostic tests to 
improve the quality of epidemiological data on yaws in endemic countries[16]. 
 
Serological methods remain the mainstay for laboratory confirmation of yaws and include both 
treponemal and non-treponemal tests. Treponemal tests such as the Treponema 
pallidum particle agglutination (TPPA) assay are highly specific, but remain positive for life 
following infection. Diagnosis of current disease therefore relies on both a positive treponemal 
test but also a reactive non-treponemal tests such as the rapid plasma regain (RPR) or the 
Venereal Disease Research Laboratory (VRDL) test. Titres of non-treponemal tests rise during 
infection and fall following successful treatment [2]. Rapid diagnostic tests that combine 
treponemal and non-treponemal components, such as the dual path platform (DPP) ‘syphilis 
screen and confirm’ assay, have now been validated for the diagnosis of yaws and have largely 
replaced traditional laboratory assays within the programmatic setting [17–20].   
 
Polymerase chain reaction (PCR) methods to detect treponemal DNA from genital ulcers of 
venereal syphilis have been available for more than two decades [21,22].  More PCR assays 
have been developed that are able to differentiate between the DNA of different subspecies of 
T.pallidum complex[14,23]. Due to primer binding-site mutations occurring in some strains of 
yaws the current recommendation is to use a pan-treponemal PCR target such as polA or tp47 
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for the diagnosis of yaws[24]. When PCR is used to assess individuals with clinical and 
serological evidence of yaws a large proportion of lesions are found to contain no treponemal 
DNA[23,25]. In several studies Haemophilus ducreyi has been demonstrated to be a common 
cause of skin lesions which may be confused with those of yaws in endemic countries in the 
South Pacific islands and Africa [15,25,26]. For this reason there is recognition that PCR will play 
an increasingly important part in yaws surveillance efforts worldwide [16]. 
 
Currently there is limited data on the optimal approach to collecting samples for molecular 
confirmation of yaws. In a number of studies samples have been collected from a single lesion 
per individual, placed in transport medium and shipped within a strict cold chain[23,25,27]. A 
number of studies assessing the use of PCR for the diagnosis of yaws have suggested that 
transport medium is unnecessary and that dry swabs perform equally well[28]. A move to dry 
swabs and shipping at ambient temperatures would reduce programmatic costs and potentially 
increase feasibility of incorporating molecular testing into the programmatic context. In this 
study we aimed to evaluate whether collection of additional swabs, from more than a single 
lesion, and the presence or absence of transport medium affected the performance of PCR for 
the diagnosis of yaws.  
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Methods 
Case Finding and Screening: 
The study was conducted in the West Akim and Upper West Akim districts in the Eastern Region 
of Ghana. These districts were selected as they are known to be highly endemic for yaws. We 
conducted active case finding searches in July 2018 in collaboration with the National Yaws 
Eradication Project (NYEP). Field workers visited schools to identify children with lesions 
consistent with yaws. Children with sores, ulcers or skin lesions were asked to come forward for 
more detailed examination as per routine NYEP protocol during case searching. Children with 
yaws-like ulcers were first screened with the SD Bioline syphilis test and those who tested 
positive were then tested with the DPP Syphilis Screen and Confirm test. Individuals with a dual 
positive (treponemal and non-treponemal) DPP assay were enrolled into the study.  
 
Swab Collection: 
We identified a maximum of 5 yaws-like lesions per individual prior to treatment. Swabs were 
taken in line with the WHO recommendations for swabbing yaws lesions. In brief, a single 
Dacron swab was used to obtain tissue from each lesion. This was performed by pressing the 
head of the swab into the centre of the lesion and rotating the swab over the area. If a lesion or 
papilloma was dry, the area was moistened using sterile saline on some gauze and the 
outermost epithelial lining was gently removed using a blunt object before swabbing. We 
identified the largest, most exudative lesions first. From this lesion paired swabs were 
collected; the first into transport medium and the second as a dry swab. From a maximum of 
four subsequent lesions we collected additional dry swabs at baseline. All individuals were then 
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offered a single-dose of azithromycin in line with national guidelines. Follow-up dry swabs were 
collected in the same manner from the first three lesions at 8, 24, 36 and 48 hours after 
treatment with azithromycin. 
 
Swab Storage 
Swabs in transport medium were placed immediately into a cool box and were frozen at -20°C 
at the laboratories of Noguchi Memorial Institute for Medical Research (NMIMR). Swabs in 
transport medium were then shipped on dry-ice to the UK where they were again frozen at -
20°C until testing. Dry swabs not in transport medium were stored at ambient temperature in 
the field for the duration of the study and shipped at ambient temperature to the UK for 
testing.  
 
Swab Testing 
DNA was extracted from lesion swabs using the QIAamp DNA Mini Kit according to the 
manufacturer’s instructions. Multiplex PCR targeting the tp47 of T. pallidum and the hhdA gene 
of H. ducreyi was performed on a Rotorgene 3000 as previously described[22]. If baseline swabs 
were PCR positive for either target, the follow-up swabs from the same lesion were extracted 
and tested using the same PCR targets. Positive and no-template controls were included in 
every PCR run. 
 
Analysis: 
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We compared the proportion of samples positive by PCR for either T. pallidum or H. ducreyi for 
the paired lesion samples collected from the ‘target’ lesion. We considered the samples 
collected in transport medium and maintained in cold chain as the gold standard and the dry 
swabs stored at ambient temperature to be the comparator. We calculated the proportion of 
individuals diagnosed with either T. pallidum or H. ducreyi based only on a swab of the target 
lesion to the proportion diagnosed based on swabbing of multiple lesions. For individuals 
whose lesion was PCR positive at baseline we assessed the number of lesions in which 
pathogen DNA remained detectable after treatment with azithromycin.  
 
Ethics Approval: 
Ethics approval for the study was obtained from the Ghana Health Services Ethics Review 
Committee and London School of Hygiene and Tropical Medicine. Parents or guardians 
provided written informed consent for children to participate in the study and where 
appropriate assent was also obtained from children.  
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Results 
Approximately 3,000 children were screened during active case searches to identify 55 
individuals with clinical evidence of yaws and a dual positive DPP assay. The median age of 
individuals enrolled in the study was 10 years (IQR 9-12) and a majority of patients were male 
(n = 33, 60%).  For dry swabs the median duration of storage at ambient temperature was 22 
days (IQR 21-32).  
 
Overall, 10 (18%) patients had at least 1 positive PCR result for T. pallidum and 12 (22%) 
patients had at least 1 positive PCR result for H. ducreyi, representing 22% of all participants. Of 
the 55 children included in this study, 53 had a swab from their target lesion collected both into 
transport medium and a dry swab at baseline. There was 100% concordance between the 
results of PCR conducted on swabs collected in transport medium and maintained in a cold 
chain and dry swabs stored at ambient temperature. 
 
Overall 111 baseline swabs were collected from the 55 patients enrolled in the study. The 
median number of swabs per patient was 2 (IQR 1-2.5). Overall a total of 14 swabs (12.6%) 
were positive for T. pallidum of which 9 swabs were from target lesions. Four swabs were 
positive from additional lesions of patients whose target lesion was also PCR-positive for T. 
pallidum. One patient had PCR confirmed yaws diagnosed based on the swab of a third lesion 
when both the target and secondary swabbed lesion were PCR-negative. Overall a total of 17 
swabs (15.3%) were positive for H. ducreyi of which 9 were from target lesions. Five swabs were 
positive from additional lesions of patients whose target lesion was also PCR-positive for H. 
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ducreyi whilst three samples were positive from individuals whose target lesion was PCR-
negative for H. ducreyi. Of 14 swabs that were positive at baseline for T. pallidum, follow-up 
swabs were available for 11 lesions. Of these 11 lesions every available follow-up swab 
remained PCR-positive, including the seven patients who had swabs collected 48 hours after 
treatment.  
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Discussion 
PCR has become an important tool in diagnosis and surveillance for yaws as part of global 
eradication efforts. In this study we demonstrate that storing swabs in transport medium and 
transporting them within a cold chain does not improve the diagnostic yield compared to dry 
swabs stored at ambient temperature. Our findings may have significant cost and logistical 
implications for programmes and should increase the feasibility of incorporating molecular 
diagnostics into routine care and surveillance activities. In addition, despite our relatively small 
sample size, we also demonstrated that the detection of T. pallidum could be increased by 
swabbing additional lesions beyond the ‘target’ lesion. Swabbing only a single lesion has been 
practice in all studies to date[15,23,25,27] but our data suggests such an approach will result in 
misclassification of cases. As the target for yaws is global eradication, detection of every case is 
vital and our study demonstrates that the approach to sample collection will need to be 
revisited to ensure cases of active yaws are not missed.  
 
Access to PCR to confirm the diagnosis of yaws remains extremely limited in all endemic 
countries outside of research studies. Diagnostic confusion with H. ducreyi and the need to 
monitor for the emergence of azithromycin resistance in T. pallidum highlight that molecular 
tools will be required to support global yaws eradication efforts[16,29]. This is the first study to 
assess the impact of the use of transport medium and a cold-chain on the diagnostic yield of 
lesion swabs for PCR. The cycle threshold (CT) value of the PCR assay was also similar for both 
dry swabs and swabs collected in transport medium (data not shown) suggesting that DNA was 
also not adversely affected by the absence of transport medium or a cold-chain.  Taken 
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together with existing studies on syphilis our data suggests that there is no benefit in using 
transport medium or a cold chain for routine diagnostic purposes. Simplifying sample 
collection, storage and transport requirements should reduce cost and improve the feasibility 
of implementing PCR as part of programmatic activities.  
 
Many patients with yaws have multiple lesions on examination however to date studies have 
focused on collecting a sample from only the largest ‘target’ lesion. Such a strategy presumes 
that all skin lesions in an individual are caused by the same pathogen. In this study we clearly 
demonstrate that this may result in missing PCR positive cases of yaws. As the aim of the WHO 
strategy is global eradication detection of every case is vital and our data strongly argues that 
consideration be given to swabbing multiple skin lesions where these are present to ensure all 
cases of active yaws are detected. We used separate swabs for each lesion and tested these 
separately. Pooling of samples for testing or use of a single swab for multiple lesions may 
facilitate similar increases in diagnostic yield whilst avoiding the additional cost of performing 
separate PCR on multiple lesions. We also demonstrated that lesions remain positive by PCR up 
to 48 hours after treatment. Whilst a positive PCR after treatment might simply represent 
detection of DNA and not viable organisms, our findings support the WHO recommendation to 
provide wound dressings as well as treatment to reduce any potential risk of ongoing 
transmission post-treatment. 
 
The major limitation of our study is the relatively small sample size. It is possible that with a 
larger number of T. pallidum PCR positive lesions that we might have been able to demonstrate 
a difference in the performance of PCR between samples collected into transport medium 
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compared to dry swabs. However, studies in syphilis have also demonstrated no difference 
between samples collected into transport medium or dry swabs [28,30,31]. Samples were 
stored at ambient temperature for a median of more than twenty days which is likely to be 
longer that the average duration of sample transport under programmatic conditions. We 
believe therefore, that our results are robust and that in routine settings there is no 
requirement for transport medium or a cold chain when collecting diagnostic samples. 
Secondly, swabbing of additional lesions detected only a single extra case of PCR confirmed 
active yaws. However, this additional case represented 10% of all cases of active yaws 
diagnosed in the study. For the global eradication campaign, it will be vital to detect every case, 
and our data strongly supports the need to consider swabbing multiple lesions when they are 
present.  
 
Conclusion 
 
Molecular tests will play a central role in surveillance and monitoring during yaws eradication 
efforts but there have been few studies evaluating how best to operationalise this tool. By 
simplifying sample collection, storage and transport and highlighting the importance of 
sampling multiple lesions, the data from our study should enable programmes to optimise their 
use of this critical diagnostic tool and support successful global eradication efforts. 
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